Distinct temporal characteristics of circulating alveolar epithelial and endothelial injury markers in ARDS with COVID-19
Authors:
Open Access
- 17 May 2021
- journal article
- letter
- Published by Springer Nature in Critical Care
- Vol. 25 (1) , 1-4
Abstract
No abstract availableAll Related Versions
This publication has 6 references indexed in Scilit:
- Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patientsCritical Care, 2021
- A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progressionLaboratory Investigation, 2020
- A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortalityCritical Care, 2020
- Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patientsThorax, 2008
- Receptor for Advanced Glycation End-Products is a Marker of Type I Cell Injury in Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Serum SP-D is a marker of lung injury in ratsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2002